Effects of tigecycline, linezolid and vancomycin on biofilms of viridans streptococci isolates from patients with endocarditis

International Journal of Artificial Organs

Volumn 30, Issue 9, 2007, Pages 798-804

  Presterl, Elisabeth ^a   Lassnigg, A ^a   Eder, M ^b   Reichmann, S ^a   Hirschl, A M ^a   Graninger, W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

Author keywords

Biofilm; Linezolid; Streptococci; Tigecycline; Vancomycin

Indexed keywords

ANTIBIOTICS; DENSITY (OPTICAL); DENSITY MEASUREMENT (OPTICAL); DISEASES; MICROWAVE INTEGRATED CIRCUITS; PROSTHETICS;

BIO-FILM THICKNESS; BIOFILM MODELS; BLOOD STREAMS; LINEZOLID; MICRODILUTION; MICROTITER PLATES; MINIMAL INHIBITORY CONCENTRATION; STREPTOCOCCUS; TIGECYCLINE; VANCOMYCIN;

BIOFILMS;

BETA LACTAM ANTIBIOTIC; GENTAMICIN; GLYCOPEPTIDE; LINEZOLID; TIGECYCLINE; VANCOMYCIN;

ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BIOFILM; CLINICAL ARTICLE; CONCENTRATION RESPONSE; DILUTION; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; GROWTH INHIBITION; HEART VALVE PROSTHESIS; HUMAN; INCUBATION TIME; MALE; MINIMUM INHIBITORY CONCENTRATION; OPTICAL DENSITY; PROSTHESIS INFECTION; QUANTITATIVE ANALYSIS;

EID: 36049036165     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703000909     Document Type: Article

References (28)

1. Fowler VG, Bayer AS, Scheld WM. Endocarditis and intravascular infections. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of infectious diseases. Philadelphia: Churchill Livingstone 2005; 975-1022.
2. Marron A, Carratala J, Gonzalez-Barca E, Fernandez-Sevilla A, Alcaide F, Gudiol F. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. Clin Infect Dis 2000; 31: 1126-30.
3. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-93.
4. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999; 37: 1771-6.
5. Corti G, Cinelli R, Paradisi F. Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic. Int J Antimicrob Agents 2000; 16: 527-30.
6. Souli M, Kontopidou FV, Koratzanis E, et al. In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals. Antimicrob Agents Chemother 2006; 50: 3166-9.
7. Presterl E, Grisold AJ, Reichmann S, Hirschl AM, Georgopoulos A, Graninger W. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics. J Antimicrob Chemother 2004; 55: 45-50.
8. Durack DT, Bright DK, Lukes AS, Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994; 96: 200-9.
9. National Committee for Clinical Laboratory Standards. Methods of dilution antimicrobial susceptibility tests for bacteria that grow aerobically: M7 approved standards, 6th ed. Wayne, PA: NCCLS; 2004. p 1-46.
10. Christensen GD, Simpson WA, Younger JJ, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985; 22: 996-1006.
11. Baldassarri L, Simpson WA, Donelli G, Christensen GD. Variable fixation of staphylococcal slime by different histochemical fixatives. Eur J Clin Microbiol Infect Dis 1993; 12: 866-8.
12. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-22.
13. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation (Review). Int J Artif Organs 2005; 28: 1062-8.
14. Mack D, Rohde H, Harris LG, Davies AP, Horstkotte MA, Knobloch JK. Biofilm formation in medical device-related infection. Int J Artif Organs 2006; 29: 343-59.
15. Arciola CR, Alvi FI, An YH, Campoccia D, Montanaro L. Implant infection and infection resistant materials: a mini review. Int J Artif Organs 2005; 28: 1119-25.
16. Cvitkovitch DG, Li YH, Ellen RP. Quorum sensing and biofilm formation in Streptococcal infections. J Clin Invest 2003; 112: 1626-32.
17. Anwar H, Strap JL, Costerton JW. Eradication of biofilm cells of Staphylococcus aureus with tobramycin and cephalexin. Can J Microbiol 1992; 38: 618-25.
18. Westling K, Julander I, Ljungman P, Jalal S, Nord CE, Wretlind B. Viridans group streptococci in blood culture isolates in a Swedish university hospital: antibiotic susceptibility and identification of erythromycin resistance genes. Int J Antimicrob Agents 2006; 28: 292-6.
19. Pankey GA, Sabath LD. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin Infect Dis 2004; 38: 864-70.
20. Shanson DC. New guidelines for the antibiotic treatment of streptococcal, enterococcal and staphylococcal endocarditis. J Antimicrob Chemother 1998; 42: 292-6.
21. Archuleta S, Murphy B, Keller MJ. Successful treatment of vancomycin-resistant Enterococcus faecium endocarditis with linezolid in a renal transplant recipient with human immunodeficiency virus infection. Transpl Infect Dis 2004; 6: 117-9.
22. Bassetti M, Di BA, Del B, V, Cenderello G, Bassetti D. Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid. Int J Antimicrob Agents 2004; 24: 83-4.
23. Zimmer SM, Caliendo AM, Thigpen MC, Somani J. Failure of linezolid treatment for enterococcal endocarditis. Clin Infect Dis 2003; 37: e29-e30.
24. Jacqueline C, Batard E, Perez L, et al. In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model. Antimicrob Agents Chemother 2002; 46: 3706-11.
25. Chiang FY, Climo M. Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47: 3002-4.
26. Wilcox MH, Kite P, Mills K, Sugden S. In situ measurement of linezolid and vancomycin concentrations in intravascular catheter-associated biofilm. J Antimicrob Chemother 2001; 47: 171-5.
27. Curtin J, Cormican M, Fleming G, Keelehan J, Colleran E. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 2003; 47: 3145-8.
28. Gander S, Hayward K, Finch R. An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model. J Antimicrob Chemother 2002; 49: 301-8.